AEON Biopharma
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -7,736 | -10,356 |
EBIT | -7,760 | -10,381 |
Net Income | 164,112 | -118,018 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -8,116 | -8,600 |
Cash | 3,442 | 1,558 |
Basic Shares | 38,843 | 37,268 |
Annual Financials
| Values in thousands | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $2,518 |
Gross Profit | 2,518 | ||
EBITDA | -48,361 | -7,912 | -22,142 |
EBIT | -48,429 | -7,915 | -16,388 |
Net Income | -52,556 | -55,637 | -32,913 |
Net Change In Cash | 0 | 0 | 2,518 |
Free Cash Flow | -35,890 | -28,603 | -9,461 |
Cash | 9,746 | 5,128 | 20,168 |
Basic Shares | 21,427 | 21,996 | 14,796 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.16 |
2024-06-30 | $0.07 |
2024-03-31 | -$0.28 |
2023-12-31 | -$0.71 |
